Mary B. Abraham

2.1k total citations
62 papers, 1.1k citations indexed

About

Mary B. Abraham is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Mary B. Abraham has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Surgery and 22 papers in Genetics. Recurrent topics in Mary B. Abraham's work include Diabetes Management and Research (34 papers), Pancreatic function and diabetes (29 papers) and Diabetes and associated disorders (21 papers). Mary B. Abraham is often cited by papers focused on Diabetes Management and Research (34 papers), Pancreatic function and diabetes (29 papers) and Diabetes and associated disorders (21 papers). Mary B. Abraham collaborates with scholars based in Australia, United States and New Zealand. Mary B. Abraham's co-authors include Timothy W. Jones, Elizabeth A. Davis, Grant J. Smith, Diana Naranjo, Beate Karges, Abiola Oduwole, Martin Tauschmann, Marie‐Anne Burckhardt, David M. Maahs and Geoffrey Ambler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Critical Care Medicine.

In The Last Decade

Mary B. Abraham

55 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary B. Abraham Australia 18 690 559 470 117 75 62 1.1k
Anke Schwandt Germany 16 853 1.2× 498 0.9× 610 1.3× 44 0.4× 27 0.4× 36 1.1k
Gül Yeşiltepe Mutlu Türkiye 15 256 0.4× 184 0.3× 170 0.4× 77 0.7× 92 1.2× 75 700
Agnieszka Szypowska Poland 20 1.0k 1.5× 732 1.3× 823 1.8× 127 1.1× 37 0.5× 85 1.4k
Eggert Lilienthal Germany 17 552 0.8× 408 0.7× 378 0.8× 30 0.3× 19 0.3× 34 814
Ian Louis Ross South Africa 17 335 0.5× 177 0.3× 70 0.1× 69 0.6× 26 0.3× 51 790
Kathleen Moran United States 11 81 0.1× 760 1.4× 353 0.8× 112 1.0× 62 0.8× 21 1.1k
Jung Su Lee Japan 13 259 0.4× 83 0.1× 107 0.2× 28 0.2× 169 2.3× 37 725
Michael S. Stalvey United States 14 152 0.2× 126 0.2× 165 0.4× 47 0.4× 16 0.2× 34 743
Francesca Laghi Italy 12 63 0.1× 264 0.5× 148 0.3× 183 1.6× 80 1.1× 17 756
Francesco De Peppo Italy 16 83 0.1× 317 0.6× 71 0.2× 136 1.2× 57 0.8× 45 632

Countries citing papers authored by Mary B. Abraham

Since Specialization
Citations

This map shows the geographic impact of Mary B. Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary B. Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary B. Abraham more than expected).

Fields of papers citing papers by Mary B. Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary B. Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary B. Abraham. The network helps show where Mary B. Abraham may publish in the future.

Co-authorship network of co-authors of Mary B. Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Mary B. Abraham. A scholar is included among the top collaborators of Mary B. Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary B. Abraham. Mary B. Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abraham, Mary B., Aris Siafarikas, A. M. Blackmore, et al.. (2025). Septo-optic dysplasia and gastroschisis: trends in birth prevalence and association with maternal age. European Journal of Pediatrics. 184(5). 297–297.
2.
Abraham, Mary B., et al.. (2025). Resting Energy Expenditure and Metabolic Features in Children With Septo-Optic Dysplasia. Journal of the Endocrine Society. 9(4). bvaf031–bvaf031.
3.
Zhou, Yongwen, Craig Jefferies, Ryan Paul, et al.. (2025). Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery. Diabetes Technology & Therapeutics. 27(5). 386–394.
4.
Abraham, Mary B., Grant J. Smith, Julie Dart, et al.. (2024). Glycemic and Psychosocial Outcomes of Advanced Hybrid Closed-Loop Therapy in Youth With High HbA1c: A Randomized Clinical Trial. Diabetes Care. 48(1). 67–75. 5 indexed citations
5.
Marmarosh, Cheri L., et al.. (2024). The psychological vital signs of incurable cancer: implications for training and practice. SHILAP Revista de lepidopterología. 1(1). 1 indexed citations
6.
7.
Abraham, Mary B., Grant J. Smith, Julie Dart, Elizabeth A. Davis, & Timothy W. Jones. (2024). Clinical Outcomes with MiniMed TM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 26(5). 341–345. 10 indexed citations
8.
Abraham, Mary B., Arcelia Arrieta, Zheng Dai, et al.. (2024). Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience. Diabetes Technology & Therapeutics. 26(3). 190–197. 5 indexed citations
9.
10.
Smith, Grant J., Mary B. Abraham, Martin de Bock, et al.. (2023). Impact of Missing Data on the Accuracy of Glucose Metrics from Continuous Glucose Monitoring Assessed Over a 2-Week Period. Diabetes Technology & Therapeutics. 25(5). 356–362. 11 indexed citations
11.
Abraham, Mary B., et al.. (2023). Impact of Body Composition on the Accuracy of a Medtronic Guardian Continuous Glucose Monitoring System. Diabetes Technology & Therapeutics. 25(8). 549–553. 2 indexed citations
12.
Taplin, Craig E., Mary B. Abraham, Grant J. Smith, et al.. (2023). Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models. Frontiers in Endocrinology. 14. 1178958–1178958. 12 indexed citations
13.
Pease, Anthony, Emily Callander, Ella Zomer, et al.. (2022). The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth. Diabetes Care. 45(9). 1971–1980. 10 indexed citations
14.
Roberts, Alison, Leanne Fried, Julie Dart, et al.. (2022). Hybrid closed‐loop therapy with a first‐generation system increases confidence and independence in diabetes management in youth with type 1 diabetes. Diabetic Medicine. 39(9). e14907–e14907. 11 indexed citations
15.
Pease, Anthony, Mary B. Abraham, Maria E. Craig, et al.. (2021). Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group. The Medical Journal of Australia. 215(10). 473–478. 10 indexed citations
16.
Burckhardt, Marie‐Anne, Mary B. Abraham, Julie Dart, et al.. (2021). Impact of Hybrid Closed Loop Therapy on Hypoglycemia Awareness in Individuals with Type 1 Diabetes and Impaired Hypoglycemia Awareness. Diabetes Technology & Therapeutics. 23(7). 482–490. 25 indexed citations
17.
Bock, Martin de, Sybil A. McAuley, Mary B. Abraham, et al.. (2018). Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 8(8). e020275–e020275. 11 indexed citations
18.
Abraham, Mary B., et al.. (2015). Surgically managed perinatal testicular torsion: a single centre experience. The Journal of Maternal-Fetal & Neonatal Medicine. 29(8). 1265–1268. 15 indexed citations
19.
Abraham, Mary B., et al.. (2014). Efficacy of Hydrochlorothiazide and low renal solute feed in Neonatal Central Diabetes Insipidus with transition to Oral Desmopressin in early infancy. International Journal of Pediatric Endocrinology. 2014(1). 11–11. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anke Schwandt Breakdown of academic impact, for papers by Gül Yeşiltepe Mutlu Breakdown of academic impact, for papers by Agnieszka Szypowska Breakdown of academic impact, for papers by Eggert Lilienthal Breakdown of academic impact, for papers by Ian Louis Ross Breakdown of academic impact, for papers by Kathleen Moran Breakdown of academic impact, for papers by Jung Su Lee Breakdown of academic impact, for papers by Michael S. Stalvey Breakdown of academic impact, for papers by Francesca Laghi Breakdown of academic impact, for papers by Francesco De Peppo
Rankless by CCL
2026